124 related articles for article (PubMed ID: 36822873)
1. Identification of high-risk features in mucinous cystic neoplasms of the pancreas.
Servin-Rojas M; Fong ZV; Fernandez-Del Castillo C; Ferrone CR; Rocha-Castellanos DM; Roldan J; Zelga PJ; Warshaw AL; Lillemoe KD; Qadan M
Surgery; 2023 May; 173(5):1270-1274. PubMed ID: 36822873
[TBL] [Abstract][Full Text] [Related]
2. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
[TBL] [Abstract][Full Text] [Related]
4. Imaging and Cytopathological Criteria Indicating Malignancy in Mucin-Producing Pancreatic Neoplasms: A Series of 68 Histopathologically Confirmed Cases.
Salla C; Karvouni E; Nikas I; Ikonomakis A; Konstantinou P; Karoumpalis I; Sepsa A; Papaparaskeva K; Tsopanomichalou M; Georgiadou D; Kostopoulou A; Tsiotos G; Theocharis S; Sergentanis TN; Politi E
Pancreas; 2018; 47(10):1283-1289. PubMed ID: 30308535
[TBL] [Abstract][Full Text] [Related]
5. Mucinous cystic neoplasms of the pancreas: high-resolution cross-sectional imaging features with clinico-pathologic correlation.
Garces-Descovich A; Beker K; Castillo-Angeles M; Brook A; Resnick E; Shinagare S; Najarian RM; Mortele KJ
Abdom Radiol (NY); 2018 Jun; 43(6):1413-1422. PubMed ID: 28936758
[TBL] [Abstract][Full Text] [Related]
6. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
[TBL] [Abstract][Full Text] [Related]
7. One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.
Hata T; Sakata N; Motoi F; Unno M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23420728
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
9. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
[TBL] [Abstract][Full Text] [Related]
11. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
12. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
13. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis and prognosis factors of malignancy in the patients with mucinous cystic neoplasms of the pancreas].
Li WL; Xu YD; Han X; Wu WC; Lou WH;
Zhonghua Wai Ke Za Zhi; 2020 Mar; 58(3):225-229. PubMed ID: 32187927
[No Abstract] [Full Text] [Related]
15. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
16. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
17. Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance.
Marchegiani G; Andrianello S; Crippa S; Pollini T; Belfiori G; Gozzini L; Cassalia F; Caravati A; Luchini C; Doglioni C; Bassi C; Falconi M; Salvia R
Br J Surg; 2021 Sep; 108(9):1097-1104. PubMed ID: 34059873
[TBL] [Abstract][Full Text] [Related]
18. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
